Zai Lab Correlations
| ZLAB Stock | USD 19.39 0.02 0.10% |
The current 90-days correlation between Zai Lab and Legend Biotech Corp is 0.3 (i.e., Weak diversification). The correlation of Zai Lab is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Zai Lab Correlation With Market
Very good diversification
The correlation between Zai Lab and DJI is -0.28 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Zai Lab and DJI in the same portfolio, assuming nothing else is changed.
Moving against Zai Stock
| 0.34 | VANI | Vivani Medical | PairCorr |
| 0.34 | ALSEN | Sensorion SA | PairCorr |
| 0.6 | VERA | Vera Therapeutics | PairCorr |
| 0.52 | DXB | Dimerix | PairCorr |
| 0.35 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.65 | HDP1 | Arrowhead Pharmaceuticals | PairCorr |
| 0.58 | VNDA | Vanda Pharmaceuticals Trending | PairCorr |
| 0.39 | 9OF | BIORESTORATTHERAPDL | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Zai Stock performing well and Zai Lab Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zai Lab's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LEGN | 2.61 | (0.44) | 0.00 | 1.19 | 0.00 | 4.19 | 19.65 | |||
| IRON | 2.79 | (0.38) | 0.00 | (2.74) | 0.00 | 4.42 | 27.84 | |||
| AAPG | 2.65 | (0.36) | 0.00 | (0.93) | 0.00 | 5.25 | 16.72 | |||
| SRRK | 2.42 | 0.31 | 0.07 | (1.13) | 2.66 | 5.76 | 14.33 | |||
| IDYA | 2.05 | (0.12) | 0.00 | (0.06) | 0.00 | 5.53 | 10.56 | |||
| CNTA | 1.85 | (0.03) | 0.00 | 0.86 | 0.00 | 4.04 | 13.05 | |||
| XENE | 1.68 | 0.14 | 0.03 | 0.65 | 1.90 | 3.78 | 10.56 | |||
| CDTX | 4.25 | 1.61 | 0.64 | 1.15 | 1.30 | 5.93 | 105.72 | |||
| TARS | 1.79 | (0.14) | 0.00 | (0.11) | 0.00 | 4.24 | 10.88 | |||
| APGE | 2.05 | 0.13 | 0.03 | 0.31 | 3.02 | 4.97 | 20.16 |
Zai Lab Corporate Management
| Peter Huang | Chief Officer | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Joshua Smiley | Chief Officer | Profile | |
| Frazor III | Chief Sec | Profile | |
| Christine Chiou | Senior Relations | Profile | |
| Harald MD | Autoimmune Neuroscience | Profile |